Design and Synthesis of HIF-1 Inhibitors as Anti-cancer Therapeutics
Cancer is responsible for one fourth of the total deaths and is the second leading cause of death, behind heart disease, in the United States. However, there are as many approaches to curing cancer as there are types of cancer. One important issue in solid tumors is hypoxia, a lack of oxygen, which...
Main Author: | Burroughs, Sarah |
---|---|
Format: | Others |
Published: |
Digital Archive @ GSU
2013
|
Subjects: | |
Online Access: | http://digitalarchive.gsu.edu/chemistry_diss/78 http://digitalarchive.gsu.edu/cgi/viewcontent.cgi?article=1078&context=chemistry_diss |
Similar Items
-
Design, Synthesis and Mechanistic Studies of Small Molecule Inhibitors of the Hypoxia Inducible Factor Pathway
by: Mooring, Suazette Reid
Published: (2010) -
Design and Synthesis of Small-molecule Inhibitors of the Hypoxia Inducible Factor-1 as Anticancer Therapeutics
by: De Los Santos, Zeus Allen O.
Published: (2014) -
HIF-α Prolyl Hydroxylase Inhibitors and Their Implications for Biomedicine: A Comprehensive Review
by: Kiichi Hirota
Published: (2021-04-01) -
Specific Inhibition of HIF Activity: Can Peptides Lead the Way?
by: Ilias Mylonis, et al.
Published: (2021-01-01) -
Design and Synthesis of Thiamine Analogs as Anti-Cancer Therapeutics
by: Dinh, Hieu T.
Published: (2012)